ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NWBO Northwest Biotherapeutics Inc (QB)

0.46
-0.00594 (-1.27%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Northwest Biotherapeutics Inc (QB) USOTC:NWBO OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.00594 -1.27% 0.46 0.451 0.4699 0.48 0.458 0.465 1,273,919 21:30:14

IQST - EV & Hi-Tech Company Poised For Potential 4X ROI - Q3 Financials and Short Squeeze

14/10/2021 4:34pm

InvestorsHub NewsWire


October 14, 2021 -- InvestorsHub NewsWire -- via pennymillions -- 

iQSTEL, Inc. (OTCQX: IQST) is on track to meet a $60.5 million annual revenue forecast.  The upcoming Q3 report could be a trigger to catapult the stock from its plus or minus $0.50 price back to its well deserved $2.00 52 week high delivering a 4X ROI.

 

IQST Q to Q Revenue In Millions


The company has been growing its topline quarter-to-quarter and the upcoming Q3 financial report is likely to show another quarter-to-quarter revenue expansion in addition to a further validation of the $60.5 million annual revenue forecast being in reach.

Perfect Storm – EV Market Entry, Q3 Financials and Short Squeeze

IQST is on the verge of making its Electric Vehicle (EV) market debut with the delivery of its first batch of electric motorcycles into South America.

IQST – iQSTEL Releases Sneak Peek Of EVOSS Electric Motorcycle Deploying Soon (Video)

As crazy as it sounds with consistent quarter-to-quarter growth and the impending Q3 report on the horizon combined with the imminent entry into the red-hot EV market, someone is hedging against IQST’s ongoing performance.  Recent trading has seen consistent short selling with nearly half of the daily volume being reported by FINRA as short sales.
 

IQST Q to Q Revenue In Millions

https://www.otcshortreport.com/company/IQST

 


A consistent Q3 report + EV Entry + Short Squeeze = A Potential Rally Back To $2.00

Source - https://www.pennymillions.com/blog/jvo1l3avbnicptdciuc3yoad8ptxqv

Other stocks on the move include AMBL, ALPP and NWBO.

 

SOURCE: pennymillions

 

1 Year Northwest Biotherapeutics (QB) Chart

1 Year Northwest Biotherapeutics (QB) Chart

1 Month Northwest Biotherapeutics (QB) Chart

1 Month Northwest Biotherapeutics (QB) Chart

Your Recent History

Delayed Upgrade Clock